AzTrials
AzTrials

Esophageal Motility DisordersNCT05380791

Effect of Esophageal Contractile Reserve on Changes in Esophageal Motility and Symptoms After ARS in Patients With GERD

An observational study of Esophageal Motility Disorders, run by Shandong University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

rapid swallow (MRS) can assess the contractile reserve capacity of the oesophageal body and identify and diagnose oesophageal motility disorders, but the impact of preoperative oesophageal reserve capacity on postoperative symptoms and motility in patients with GERD remains unclear. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Esophageal Motility Disorders
What is being tested?
Follow-up visits
How many people
70 participants
Where
1 siteChina
Study dates
22 Apr 2022to 1 Jun 2026
How long will I take part?
2 Years
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients to be treated surgically for gastroesophageal reflux disease. Ineffective esophageal motility diagnosed by high resolution esophageal according to Chicago Classification version 4.0(defined as ≥ 70% of swallows with weak contraction (distal contraction interval (DCI) between 100mmHg/s/cm and less than 450 mmHg/s/cm) or ≥ 50% of swallows with failed peristalsis Performance.

Who may be able to join

  • Age over 18 years old
  • Patients to be treated surgically for gastroesophageal reflux disease
  • Ineffective esophageal motility diagnosed by high resolution esophageal manometry according to Chicago Classification version 4.0
  • Obtaining Informed Consent

Who cannot join

  • Previous other upper gastrointestinal surgery
  • Pregnant women and other people with contraindications to surgery and tests
  • Other specifically defined esophageal motility disorders, such as nutcracker esophagus

Trial locations and contacts

1 site in 1 country.

FeiXue Chen, MD contact

18560086108

qlxhkqz@163.com

China1 site, 1 recruiting
  • Department of Gastroenterology, Qilu Hospital, Shandong University

    Jinan, Shandong, 250012

    Yanqing Li, PhD. MD., 18678827666, liyanqing@sdu.edu.cn

    Recruiting

Other trials in China

About this study

Official title: Effect of Esophageal Contractile Reserve on Changes in Esophageal Motility and Symptoms After Anti-reflux Surgery in Patients With Gastroesophageal Reflux Disease

rapid swallow (MRS) can assess the contractile reserve capacity of the oesophageal body and identify and diagnose oesophageal motility disorders, but the impact of preoperative oesophageal reserve capacity on postoperative symptoms and motility in patients with GERD remains unclear. The aim of this study was to assess the effect of pre-operative oesophageal reserve capacity on post-reflux symptoms and motility in patients with GERD by using a high-resolution oesophageal manometry-based provocation test, MRS, to track pre-operative ineffective oesophageal motility (IEM).

Read the detailed description

Lower oesophageal sphincter relaxation is an important cause of GERD and ineffective oesophageal motility may be associated with GERD, but the mechanism of oesophageal corporal motility disorders is unclear. High-resolution manometry (HRM) has shown to be more accurate than conventional manometry in assessing oesophageal motility, and can provide guidance for GERD surgery. The aim was to conduct a cohort study to investigate the yu'h of patients with preoperative esophageal motility disorders with or without esophageal reserve, based on the assessment of esophageal motility by high-resolution esophageal manometry to follow up changes in esophageal motility and symptoms in patients after anti-reflux surgery.

Being tested
Follow-up visits
Keywords
contraction reserve
Medical subject headings
Esophageal Motility Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Follow-up visitsOther

    Also called Questionnaire to assess symptoms and quality of life etc.

    Regular follow-up visits to record information about the patient's surgery and routine post-operative examinations

Study groups in NCT05380791
Study groupRoleWhat they receive
IEM in patients with GERD with normal MRS contractionEsophageal motility determined by high resolution esophageal manometry and multiple rapid swallow (MRS) tests
Receives: Other: Follow-up visits
IEM in patients with GERD with abnormal MRS contractionEsophageal motility determined by high resolution esophageal manometry and multiple rapid swallow (MRS) tests
Receives: Other: Follow-up visits

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Effect of changes in oesophageal motility after anti-reflux surgery compared to pre-surgery

    Using high resolution manometry to assess changes in oesophageal motility after anti-reflux surgery, compared to pre-surgery.

    Measured: 2 year follow-up after anti-reflux surgery

Secondary outcomes (1)
  1. Effect of changes of post-anti-reflux surgery symptoms

    Reflux Symptom Questionnaire Assessment to assess the changes of symptoms

    Measured: 2 year follow-up after anti-reflux surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 May 2022
  2. Study start22 Apr 2022
  3. Primary completion1 Apr 2026 (estimated)
  4. Study completion1 Jun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
70 participants (estimated)
Target duration
2 Years
IDs, dates and publications
ClinicalTrials.gov ID
NCT05380791
Sponsor's protocol ID
2022-SDU-QILU-008
Status last verified
May 2022
First submitted
21 Apr 2022
Last updated
19 May 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Esophageal Motility Disorders, run by Shandong University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 May 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact FeiXue Chen, MD (18560086108, qlxhkqz@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Effect of changes in oesophageal motility after anti-reflux surgery compared to pre-surgery (time frame: 2 year follow-up after anti-reflux surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in